The results showed that EMCN expression was significantly reduced in metastatic tumors (Fig. 1D and Additional file 1: Fig. S1D) and was strongly reduced in tumor recurrence (Fig. 1E and Additional file 1: Fig. S1E). Here, EMCN is linked to metastatic neoplasm.